JACQUELINE PAWLACZYK: Open Payments
NPI 1659745453 · WYANDOTTE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,100 in 73 payments from 14 companies in 2025. Trend: 2023 $1,853 · 2024 $1,561 · 2025 $1,100
Food & beverage: $1,080Education: $19
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $353 |
| Novartis Pharmaceuticals Corporation | 19 | $221 |
| GENZYME CORPORATION | 4 | $113 |
| Amgen Inc. | 3 | $77 |
| Organon LLC | 6 | $59 |
| UCB, Inc. | 2 | $51 |
| Regeneron Healthcare Solutions, Inc. | 2 | $45 |
| MERZ NORTH AMERICA, INC. | 1 | $45 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $39 |
| Biofrontera Inc. | 1 | $26 |
Products named: SKYRIZI, COSENTYX, DUPIXENT, RINVOQ, OTEZLA, Bimzelx, VTAMA, ILUMYA.
Industry payments across MI — which companies pay providers there.
